CRP < 1.0 μg/mL is generally regarded as low risk, 1.0-2.99 μg/mL as intermediate risk and >3 μg/mL as high risk for the development of cardiovascular disease in subjects apparently free of such disease at baseline. This evidence concerns the gene CRP and cardiovascular disorder.